BASF Asks FDA To Weigh Whole Sunscreen TEAs, Not Isolated Parts

Chemical supplier’s representatives maintain a “weight-of-evidence” approach comprising repeated dose toxicity, photo-genotoxicity, dermal carcinogenicity and photo-carcinogenicity studies is adequate to establish safety for its bemotrizinol UV filter. FDA officials heard BASF’s position in a public meeting required by the Sunscreen Innovation Act.